In conclusion, current missing evidence for the clinical application of urinary podocin to detect kidney disease in horses are: absence of assay validation data, absence of reference ranges, absence of data in foals, absence of knowledge of extrarenal effects on podocin concentrations, only 1 study with limited data available in the literature, no data on CKD. Here, NPHS2 is linked to chronic kidney disease.